Proton Power Systems (PPS) recently provided the market with a trading update informing the market that revenue for the current financial year is up 250% on the previous year. PPS also reiterated to the market that long term revenue visibility is present for many years to come. This woke the market up following the recent wins of orders earlier in the year.
Beximco Pharma (BXP) BXP informed the market that it has commenced exporting carvedilol to the US (5 August 2016) – the first Bangladeshi pharmaceutical company to do so and the market received this news positively. With the mid-price market close for BXP at 35.625p on 5 August 2016, it still remains at a massive discount to the BXP share price for its listing in Dhaka (currently the equivalent of just over ~80p!!).
Datafeed and UK data supplied by NBTrader and Digital Look.
While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.